The Evaluation of Meropenem Dosing Regimens Against ESBL-Producing Escherichia coli in ICU Patients Using Monte Carlo Simulation

PURPOSE: To evaluate the optimal dosing regimens of meropenem against extended-spectrum beta-lactamase-producing Escherichia coli (ESBL E. coli) in critically ill patients with varying degrees of renal function using Monte Carlo simulation (MCS). METHODS: The MCS was performed using the minimum inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Win, Ei Ei, Htun, Khaing Win, Tragulpiankit, Pramote, Tangtrakultham, Suwida, Montakantikul, Preecha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846559/
https://www.ncbi.nlm.nih.gov/pubmed/35177911
http://dx.doi.org/10.2147/IDR.S345385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846559/
https://www.ncbi.nlm.nih.gov/pubmed/35177911
http://dx.doi.org/10.2147/IDR.S345385

Ejemplares similares